A synthesized peptide derived from human PF4 Released during platelet aggregation. Neutralizes the anticoagulant effect of heparin because it binds more strongly to heparin than to the chondroitin-4-sulfate chains of the carrier molecule. Chemotactic for neutrophils and monocytes. Inhibits endothelial cell proliferation, the short form is a more potent inhibitor than the longer form.
Alternative Names:
Annexin A2,Annexin II,Annexin-2,Calpactin I heavy chain,Calpactin-1 heavy chain,Chromobindin-8,Lipocortin II,Placental anticoagulant protein IV,PAP-IV,Protein I,p36,ANXA2,ANX2, ANX2L4, CAL1H, LPC2D,
Boster Bio Anti-PF4 Monoclonal Antibody catalog M00871. Tested in WB, IHC, IP applications. This antibody reacts with Human, Mouse, Rat.
